Targeted Omics for Impactful Biomedical Research

In this webinar, we will take you behind the scenes of our Targeted Omics solutions/workflows, on our Tandem Quadrupole platforms, with ACQUITY Premier LC technology. There will be an overview of the Targeted Omics Method Libraries, that are free to download and consist of pre-developed methods, enabling you to expand the menu of assays provided by your lab, in a matter of hours. As part of this introduction there will also be a demonstration of the workflows, from our European Applications Lab.

Secondly, we will introduce and discuss the benefits of our COVID-19 testing kit, which enables direct detection and quantification of SARS-CoV-2 signature NCAP peptides, without the need to amplify the target analytes. The workflow can be automated, providing high accuracy and analytical sensitivity, with reproducible results between labs and is an alternative/complementary technology to common infectious pathogen research.  

Key Learning Objectives:

• Benefits of ACQUITY Premier LC technology for Biomedical Research/Targeted Omics
• Benefits of Waters Targeted Omics Workflows/Method Libraries on Tandem Quadrupole platforms
• Development and use of SARS-CoV-2 testing kit an alternative/complementary technology to common infectious pathogen research.  
• Hear why customers like you choose to partner with Waters

Who Should Attend:

Academic and Industrial researchers with an interest in Targeted Omics, using Tandem Quadrupole technology.

Anyone interested in SARS-Cov-2 research and testing techniques which complement/provide an alternative to PCR.

Presenter: Billy Molly (Principal Scientist, Waters Corporation)

Billy Molloy is a Principal Scientist in the Scientific Operations Group at Waters Corporation, specialising in the development of bio-analytical LC/MS applications. He has 25 years of experience across various fields including Pharmaceuticals, Clinical, Biomedical Research and Life Sciences.

He has extensive knowledge of regulated, as well as non-regulated environments, ranging from fast turnaround discovery bio-analysis, to the most challenging bio-analytical problems.

Presenter: Samantha Ferries (Applications Chemist, Waters Corporation)

Samantha Ferries is an Applications Chemist in the UK Demo Lab at Waters Corporation. She received her PhD in proteomics from the University of Liverpool in 2018. Since joining Waters in 2018, Samantha has worked on a variety of application areas including Pharmaceuticals, Food & Environmental and Biomedical Research, with a focus on LCMS/MS method development. In 2021 Samantha was part of the team that worked to develop the SARS-CoV-2 LCMS Kit (RUO) to detect & quantify SARS-CoV-2 signature NCAP peptides.